Skip to main content

Hepatocyte growth factor controls bone marrow rejection

Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function of donor cells.

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

Acute graft-versus-host disease (GVHD) is a major complication of bone marrow transplantation. In June 1 Journal of Clinical Investigation, Takanori Kuroiwa and colleagues from Hyogo College of Medicine, Nishinomiya, Japan show that hepatocyte growth factor (HGF) — a potent mitogen for hepatocytes — ameliorates acute graft-versus-host disease and promotes hematopoietic function.

Kuroiwa et al used a murine model of GVHD in which they performed repeated transfection of the human HGF cDNA by liposome injection into the gluteal muscle. This treatment inhibited apoptosis of intestinal epithelial cells and donor T-cell infiltration into the liver, thereby ameliorating the enteropathy and liver injury caused by acute GVHD. In addition, the HGF gene transfer induced an increase of extramedullary hematopoiesis by donor cells in the spleen and liver (J Clin Invest, 2001, 107:1365-1373).

These results open the possibility of the use of HGF gene therapy to control acute GVHD following allogeneic bone marrow transplantation.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays